Brief: Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results

Twist Bioscience

05/05/2023 12:34

May 5 (Reuters) - Twist Bioscience Corp  TWST.O :
    * TWIST BIOSCIENCE REPORTS FISCAL SECOND QUARTER 2023
FINANCIAL
RESULTS
    * RESIZING MANY TEAMS THROUGHOUT ORGANIZATION AND REDUCING
ITS
WORKFORCE BY APPROXIMATELY 270 EMPLOYEES, OR ABOUT 25%
    * Q2 EARNINGS PER SHARE VIEW $-1.12, REVENUE VIEW $56.7
MILLION --
REFINITIV IBES DATA
    * MANUFACTURING FOR MAJORITY OF SYNTHETIC BIOLOGY PRODUCTS
HAS
TRANSITIONED TO FACTORY OF FUTURE
    * NGS PANELS WILL CONTINUE TO BE MADE IN SOUTH SAN FRANCISCO
    * WILL MODERATE ITS INVESTMENT IN DNA DATA STORAGE WHILE
MAINTAINING ITS COMPETITIVE LEAD
    * Q3 REVENUE VIEW $73.5 MILLION -- REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $264.2 MILLION -- REFINITIV IBES DATA
    * EXPECTS TO EXIT FISCAL 2024 WITH ADJUSTED EBITDA BREAKEVEN
FOR
ITS CORE (SYNBIO, NGS) AND BIOPHARMA BUSINESSES IN Q4

Source text for Eikon:  ID:nBw99TB9La 
Further company coverage:  TWST.O